
Company Info
Year Established2023
Contacts
Sanjeev Munshi, Ph.D.CEO
Company Description
EPOK Therapeutics specialize in the development of engineered agonist and antagonist antibodies with a focus on reducing off-target activity, enhancing safety profiles, and optimizing dosing regimens and production efficiency.
